Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma
Clinical trial NCT01861912 · UNKNOWN
Trial details
- NCT number
- NCT01861912
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-06-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.